Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-24-000356
Filing Date
2024-01-10
Accepted
2024-01-10 16:36:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 29057
2 filename2.txt TEXT-EXTRACT 3189
  Complete submission text file 0000000000-24-000356.txt   44095
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filed for) CIK: 0001855485 (see all company filings)

EIN.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-274885
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)